Published in Cancer Res on September 01, 1985
A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells. Am J Physiol Cell Physiol (2012) 1.62
Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model. Antimicrob Agents Chemother (1994) 1.08
Tumorigenicity of simian virus 40-hepatocyte cell lines: effect of in vitro and in vivo passage on expression of liver-specific genes and oncogenes. Mol Cell Biol (1988) 0.89
Pathways for the mutagenesis of 1-nitropyrene and dinitropyrenes in the human hepatoma cell line HepG2. Environ Health Perspect (1994) 0.81
Hepatitis B virus DNA detection by in situ hybridization in human hepatocellular carcinoma. Korean J Intern Med (1988) 0.75
Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med (1999) 11.19
Cimetidine: interaction with oral anticoagulants in man. Lancet (1979) 4.67
Virus-specific transcription in bovine papillomavirus-transformed mouse cells. Virology (1982) 4.52
Bioethics for clinicians: 1. Consent. CMAJ (1996) 3.60
Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene (2009) 3.51
Cloning of human papilloma virus genomic DNAs and analysis of homologous polynucleotide sequences. J Virol (1980) 3.34
Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A (1995) 3.25
A precursor-product relationship exists between oval cells and hepatocytes in rat liver. Carcinogenesis (1987) 2.98
Transcriptional organization of bovine papillomavirus type 1. J Virol (1983) 2.84
Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat Genet (1992) 2.63
Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther (1974) 2.62
Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest (1990) 2.61
Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res (1998) 2.59
In vivo differentiation of rat liver oval cells into hepatocytes. Cancer Res (1989) 2.58
The effects of oxytocin and vasopressin on partner preferences in male and female prairie voles (Microtus ochrogaster). Behav Neurosci (1999) 2.48
Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen (2000) 2.47
Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest (1996) 2.42
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene (2012) 2.41
Atypical ductular proliferation and its inhibition by transforming growth factor beta1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver disease. Lab Invest (1999) 2.16
Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res (1993) 2.09
Origin and structural evolution of the early proliferating oval cells in rat liver. Am J Pathol (2001) 2.07
Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res (1994) 2.06
Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat. Lab Invest (1994) 1.90
Dose-dependent enzyme induction. Clin Pharmacol Ther (1973) 1.84
Expression of hepatic transcription factors during liver development and oval cell differentiation. J Cell Biol (1994) 1.80
Comparative and integrative functional genomics of HCC. Oncogene (2006) 1.75
The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas. Am J Pathol (2000) 1.73
Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. Pharmacology (1974) 1.70
Origin and fate of oval cells in dipin-induced hepatocarcinogenesis in the mouse. Am J Pathol (1994) 1.67
Fast neutron therapy for squamous cell carcinoma in the head and neck region: results of a randomized trial. Int J Radiat Oncol Biol Phys (1987) 1.65
Changes in liver blood flow during enzyme induction. Biochem Pharmacol (1971) 1.65
Precision cutting and patterning of graphene with helium ions. Nanotechnology (2009) 1.64
Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis. J Clin Invest (1984) 1.63
Interindividual differences in rates of drug oxidation in man. Drug Metab Dispos (1974) 1.63
Expression of acidic fibroblast growth factor in regenerating liver and during hepatic differentiation. Lab Invest (1992) 1.63
Interobserver and intraobserver variation in classification systems for fractures of the distal humerus. J Bone Joint Surg Br (2000) 1.60
Smoking and industrial pollution, and their effects on menopause and ovarian cancer. Lancet (1978) 1.59
Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology (2000) 1.59
Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis. Hepatology (1992) 1.58
The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice. Proc Natl Acad Sci U S A (1996) 1.56
Novel recurrent genetic imbalances in human hepatocellular carcinoma cell lines identified by comparative genomic hybridization. Hepatology (1999) 1.50
Cloned human polyomavirus JC DNA can transform human amnion cells. J Virol (1980) 1.50
NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice. Mol Cell Biol (1985) 1.48
The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program. Diabetes Care (1993) 1.47
Differential effects of transforming growth factor-beta on proliferation of normal and malignant rat liver epithelial cells in culture. Cancer Res (1986) 1.43
Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters. Pharmacology (1974) 1.43
Dynamics of reactive oxygen intermediate production in human glioma: n-6 essential fatty acid effects. Eur J Clin Invest (1999) 1.42
Prenatal screening for open neural-tube defects in Maine. N Engl J Med (1999) 1.42
Expression of cellular myc and mos genes in undifferentiated B cell lymphomas of Burkitt and non-Burkitt types. Proc Natl Acad Sci U S A (1983) 1.42
Activation of hepatic stem cell compartment in the rat: role of transforming growth factor alpha, hepatocyte growth factor, and acidic fibroblast growth factor in early proliferation. Cell Growth Differ (1993) 1.38
Pulmonary nodules: effect on detection of spiral CT pitch. Radiology (1996) 1.38
Tracheal mucus flow rates in experimental bronchitis in rats. Br J Exp Pathol (1969) 1.38
Canadian physicians and euthanasia: 2. Definitions and distinctions. CMAJ (1993) 1.35
Partial cloning of rat CD34 cDNA and expression during stem cell-dependent liver regeneration in the adult rat. Hepatology (1997) 1.34
Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis. Oncogene (2000) 1.33
Oval cell differentiation into hepatocytes in the acetylaminofluorene-treated regenerating rat liver. Hepatology (1995) 1.33
Association of p21ras with phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A (1991) 1.30
Protective and disease-enhancing immune responses to respiratory syncytial virus. J Infect Dis (1995) 1.30
Precursor-product relationship between oval cells and hepatocytes: comparison between tritiated thymidine and bromodeoxyuridine as tracers. Carcinogenesis (1996) 1.29
Expression of hepatocyte growth factor and c-met genes during hepatic differentiation and liver development in the rat. Am J Pathol (1993) 1.28
Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver. Science (1987) 1.28
Cubital tunnel external compression syndrome. Br Med J (1973) 1.28
Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide. Lancet (1990) 1.28
The Ah locus and the metabolism of chemical carcinogens and other foreign compounds. Adv Cancer Res (1977) 1.27
An audit of the effect of a 24-hour emergency operating theatre in a district general hospital. Ann R Coll Surg Engl (1994) 1.25
Oxytocin and social bonding. Ann N Y Acad Sci (1992) 1.23
Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. Cancer Res (1998) 1.23
Results of two randomised clinical trials of neutron therapy in rectal adenocarcinoma. Radiother Oncol (1987) 1.22
Modulation of keratin 14 and alpha-fetoprotein expression during hepatic oval cell proliferation and liver regeneration. J Cell Physiol (1994) 1.22
Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade. Cancer Res (2001) 1.22
Transforming growth factor-beta 1 and type I procollagen transcripts during regeneration and early fibrosis of rat liver. Lab Invest (1990) 1.22
Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells. Mol Cell Biol (2000) 1.21
Vascular endothelial growth factor receptors in osteoclast differentiation and function. Biochem Biophys Res Commun (2005) 1.21
Contribution of CYLN2 and GTF2IRD1 to neurological and cognitive symptoms in Williams Syndrome. Neurobiol Dis (2006) 1.21
A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol Pharmacol (1993) 1.20
Mechanism of hepatic drug oxidation and its relationship to individual differences in rates of oxidation in man. Ann N Y Acad Sci (1971) 1.20
Deficient DNA repair in human progeroid cells. Proc Natl Acad Sci U S A (1973) 1.20
Quantitative approaches for assessing dose-response relationships in genetic toxicology studies. Environ Mol Mutagen (2012) 1.19
NANOG modulates stemness in human colorectal cancer. Oncogene (2012) 1.19
Reduced growth capacity of hepatocytes from c-myc and c-myc/TGF-alpha transgenic mice in primary culture. Biochem Biophys Res Commun (1996) 1.18
Activated Raf-1 causes growth arrest in human small cell lung cancer cells. J Clin Invest (1998) 1.17
Carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates: induction of tumors in three macaques. Jpn J Cancer Res (1990) 1.16
Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas. Clin Cancer Res (1997) 1.16
Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications. J Hepatol (2010) 1.16
Derivation of point of departure (PoD) estimates in genetic toxicology studies and their potential applications in risk assessment. Environ Mol Mutagen (2014) 1.15
In vivo infusion of growth factors enhances the mitogenic response of rat hepatic ductal (oval) cells after administration of 2-acetylaminofluorene. Hepatology (1996) 1.14
Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha. Am J Pathol (1996) 1.14
Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Cancer Res (1995) 1.13
The glioma-polyposis syndrome. N Engl J Med (1969) 1.12
Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics. J Natl Cancer Inst (1988) 1.11
Comparison of two independent Sr optical clocks with 1×10(-17) stability at 10(3) s. Phys Rev Lett (2012) 1.10
In situ hybridization studies on expression of albumin and alpha-fetoprotein during the early stage of neoplastic transformation in rat liver. Cancer Res (1987) 1.10
Proliferation, apoptosis, and induction of hepatic transcription factors are characteristics of the early response of biliary epithelial (oval) cells to chemical carcinogens. Hepatology (1996) 1.10
Psychiatric comorbidities in patients with Parkinson disease and psychosis. Neurology (2004) 1.10
An analysis of the radiation related morbidity observed in a randomized trial of neutron therapy for bladder cancer. Int J Radiat Oncol Biol Phys (1986) 1.09
Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver. Am J Pathol (1999) 1.09
Canadian physicians and euthanasia: 5. Policy options. CMAJ (1993) 1.09
Expression of transforming growth factor-alpha in regenerating liver and during hepatic differentiation. Mol Carcinog (1992) 1.09